Patents by Inventor Kemal Payza

Kemal Payza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230248736
    Abstract: Provided herein are methods for the treatment of avoiding loss of taste response while treating a chronic cough patient with a selective P2X3 modulator.
    Type: Application
    Filed: September 14, 2022
    Publication date: August 10, 2023
    Inventors: Denis GARCEAU, Antonios MATZOURANIS, Roberto BELLINI, Kemal PAYZA, Nathalie CHAURET, Susan E. BROWNE
  • Publication number: 20220160724
    Abstract: Provided herein are methods for the treatment of avoiding loss of taste response while treating a chronic cough patient with a selective P2X3 modulator.
    Type: Application
    Filed: February 11, 2022
    Publication date: May 26, 2022
    Inventors: Denis GARCEAU, Antonios MATZOURANIS, Roberto BELLINI, Kemal PAYZA, Nathalie CHAURET, Susan E. BROWNE
  • Publication number: 20220002292
    Abstract: Described herein are crystalline forms of a P2X3 modulator, namely (S)-methyl-2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl-7-methylimidazo[1,2-a]pyridin-3-yl)methyl)morpholine-4-carboxylate or a solvate thereof, and use thereof for treating pain, urinary tract disorder, cough, pruritus and endometriosis.
    Type: Application
    Filed: November 12, 2019
    Publication date: January 6, 2022
    Inventors: Denis GARCEAU, Robert M. WENSLOW, Jr., Kemal PAYZA, Nathalie CHAURET
  • Publication number: 20210322432
    Abstract: Provided herein are methods for the treatment of avoiding loss of taste response while treating a chronic cough patient with a selective P2X3 modulator.
    Type: Application
    Filed: June 29, 2021
    Publication date: October 21, 2021
    Inventors: Denis GARCEAU, Antonios MATZOURANIS, Roberto BELLINI, Kemal PAYZA, Nathalie CHAURET, Susan E. BROWNE
  • Publication number: 20210069201
    Abstract: Provided herein are methods for the treatment of avoiding loss of taste response while treating a chronic cough patient with a selective P2X3 modulator.
    Type: Application
    Filed: November 17, 2020
    Publication date: March 11, 2021
    Inventors: Denis GARCEAU, Antonios MATZOURANIS, Roberto BELLINI, Kemal PAYZA, Nathalie CHAURET, Susan E. BROWNE
  • Publication number: 20200230148
    Abstract: The current application relates to the use of a selective P2X3 antagonist for avoiding loss of taste response while treating a chronic cough in warm-blooded animals; wherein said selective P2X3 antagonist is selective for P2X3 homomeric receptor antagonism versus P2X2/3 heteromeric receptor antagonism.
    Type: Application
    Filed: September 14, 2018
    Publication date: July 23, 2020
    Inventors: Denis GARCEAU, Antonios MATZOURANIS, Roberto BELLINI, Kemal PAYZA, Nathalie CHAURET, Susan E. BROWNE
  • Patent number: 10111883
    Abstract: Provided herein are methods for the treatment of avoiding loss of taste response while treating a chronic cough patient with a selective P2X3 modulator.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: October 30, 2018
    Assignees: BELLUS HEALTH COUGH INC., NEOMED INSTITUTE
    Inventors: Denis Garceau, Antonios Matzouranis, Roberto Bellini, Kemal Payza, Nathalie Chauret, Susan E. Browne
  • Patent number: 5908832
    Abstract: The present invention relates to an analog of Neuropeptide FF (e.g., daY8Ra) and to a pharmaceutical composition containing same. The invention further relates to methods of using the analog to attenuate the effects of drug addiction, drug tolerance, drug dependence or of abstinence syndrome.
    Type: Grant
    Filed: October 7, 1991
    Date of Patent: June 1, 1999
    Assignee: University of Houston - Clearlake
    Inventors: Kemal Payza, David H. Malin